Evidence map›Paper›PMID 31061498›Full record

ArticleNature chemical biology2019

Glycan sulfation patterns define autophagy flux at axon tip via PTPRσ-cortactin axis.

Kazuma Sakamoto, Tomoya Ozaki, Yen-Chun Ko, Cheng-Fang Tsai, Yuanhao Gong, Masayoshi Morozumi, Yoshimoto Ishikawa, Kenji Uchimura, Satomi Nadanaka, Hiroshi Kitagawa and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Neuronal Axon Generation/Regeneration Regulated by Sulfated Glycans.Advances in experimental medicine and biology · 2026
    Review
  6. Review
  7. N-Sulfated Heparan Sulfate Promotes Reelin Signaling as a Co-receptor.Journal of the American Chemical Society · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Kazuma SakamotoDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID http://orcid.org/0000-0002-2548-2574
Tomoya OzakiDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID http://orcid.org/0000-0002-2780-1524
Yen-Chun KoGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Cheng-Fang TsaiGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Yuanhao GongDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masayoshi MorozumiDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yoshimoto IshikawaDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kenji UchimuraDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Satomi NadanakaLaboratory of Biochemistry, Kobe Pharmaceutical University, Higashinada-ku, Kobe, Japan.
Hiroshi KitagawaLaboratory of Biochemistry, Kobe Pharmaceutical University, Higashinada-ku, Kobe, Japan.ORCID http://orcid.org/0000-0002-9307-7079
Medel Manuel L ZuluetaGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Anandaraju BandaruGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Jun-Ichi TamuraDepartment of Life and Environmental Agricultural Sciences, Faculty of Agriculture, Tottori University, Tottori, Japan.
Shang-Cheng HungGenomics Research Center, Academia Sinica, Taipei, Taiwan. schung@gate.sinica.edu.tw.ORCID http://orcid.org/0000-0002-8797-729X
Kenji KadomatsuDepartment of Biochemistry, Nagoya University Graduate School of Medicine, Nagoya, Japan. kkadoma@med.nagoya-u.ac.jp.ORCID http://orcid.org/0000-0002-0431-327X
Nagoya University · JPGenomics Research Center, Academia Sinica · TWKobe Pharmaceutical University · JPNational Taitung University · TWTottori University · JPUnité de Glycobiologie Structurale et Fonctionnelle · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chondroitin sulfate (CS) and heparan sulfate (HS) are glycosaminoglycans that both bind the receptor-type protein tyrosine phosphatase PTPRσ, affecting axonal regeneration. CS inhibits axonal growth, while HS promotes it. Here, we have prepared a library of HS octasaccharides and, together with synthetic CS oligomers, we found that PTPRσ preferentially interacts with CS-E-a rare sulfation pattern in natural CS-and most HS oligomers bearing sulfate and sulfamate groups. Consequently, short and long stretches of natural CS and HS, respectively, bind to PTPRσ. CS activates PTPRσ, which dephosphorylates cortactin-herein identified as a new PTPRσ substrate-and disrupts autophagy flux at the autophagosome-lysosome fusion step. Such disruption is required and sufficient for dystrophic endball formation and inhibition of axonal regeneration. Therefore, sulfation patterns determine the length of the glycosaminoglycan segment that bind to PTPRσ and define the fate of axonal regeneration through a mechanism involving PTPRσ, cortactin and autophagy.

Indexed as

AnimalsAutophagyChondroitin SulfatesCortactinHeparan SulfateHumansMiceNerve RegenerationReceptor-Like Protein Tyrosine Phosphatases, Class 5Chondroitin SulfatesCortactinHeparan SulfatePTPRG protein, humanPtprg protein, mouseReceptor-Like Protein Tyrosine Phosphatases, Class 5

Identifiers

PMID31061498
OpenAlexW2943784805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.